VPTDF - Ventripoint Diagnostics Ltd. Announces Filing of Second Amended and Restated MD&A
(TheNewswire)
Toronto, Canada – TheNewswire - October 13, 2021 – Ventripoint DiagnosticsLtd. (“ Ventripoint ” or the “ Company ”)(TSXV:VPT ) , ( OTC:VPTDF), announces that as a resultof a review by staff of the Ontario Securities Commission(“ OSC ”) it is issuing the following press release to clarify itsprevious disclosure. The Company has filed a second amended andrestated management’s discussion and analysis for the three and sixmonth period ended June 30, 2021 (the “ Second Revised MD&A ”).
The Second Revised MD&A was refiled to, among otherthings, provide enhanced disclosure of the Company’s projects,plans, expenditures made and the timing and costs anticipated toadvance the Company’s projects to the next stage. The BusinessObjectives and Milestones discussion in the Second Revised MD&Ahas been revised to include details with respect to the Company’ssales efforts and strategy, General Electric Healthcarecollaboration, VMS+4.0 timing, product design and developmentprograms, and commercialization.
The revisions reflected in the Revised MD&A havebeen made at the request of OSC staff in connection with their reviewof the Company’s preliminary short form prospectus dated October 1,2021.
ABOUT VENTRIPOINT DIAGNOSTICSLTD.
Ventripoint has become an industry leader in theapplication of AI (Artificial Intelligence) to echocardiography.Ventripoint’s VMS products are powered by its proprietary KBRtechnology, which is the result of a decade of development andprovides accurate volumetric cardiac measurements equivalent to MRI.This affordable, gold-standard alternative allows cardiologistsgreater confidence in the management of their patients. Providingbetter care to patients serves as a springboard and basic standard forall of Ventripoint’s products that guide our future developments. Inaddition, VMS+ is versatile and can be used with all ultrasoundsystems from any vendor supported by regulatory market approvals inthe U.S., Europe and Canada. For more information, please visitwww.ventripoint.com
FOR FURTHER INFORMATIONCONTACT
This news releasecontains forward-looking statements and forward-looking informationwithin the meaning of applicable securities laws. The use of any ofthe words “expect”, “anticipate”, “continue”,“estimate”, “objective”, “ongoing”, “may”, “will”,“project”, “should”, “believe”, “plans”, “intends”and similar expressions are intended to identify forward-lookinginformation or statements. The forward-looking statements andinformation are based on certain key expectations and assumptions madeby the Company. Although the Company believes that the expectationsand assumptions on which such forward-looking statements andinformation are based are reasonable, unduereliance should not be placed on the forward-looking statements andinformation because the Company can give no assurance that they willprove to be correct. Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Company’s mostrecent annual management’s discussion and analysis that is availableon the Company’s profile on SEDAR at www.sedar.com .
Readers are cautionedthat the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Company undertakes no obligation to update publicly orrevise any forward-looking statements or information, whether as aresult of new information, future events or otherwise, unless sorequired by applicable securities laws.
NOT FOR DISTRIBUTION TO U.S.NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
Copyright (c) 2021 TheNewswire - All rights reserved.